Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter
Authors:
- 1 April 1989
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 63 (13) , 925-929
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Heart, Lung, and Blood Institute
This publication has 18 references indexed in Scilit:
- Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmiasAmerican Heart Journal, 1986
- Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: A multicenter double-blind clinical trialAmerican Heart Journal, 1985
- Effects of esmolol on cardiac function: Evaluation by noninvasive techniquesThe American Journal of Cardiology, 1985
- Basic pharmacology of esmololThe American Journal of Cardiology, 1985
- Esmolol: A new ultrashort-acting beta-adrenergic blocking agent for rapid control of heart rate in postoperative supraventricular tachyarrhythmiasJACC, 1985
- Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metaboliteClinical Pharmacology & Therapeutics, 1983
- Pharmacology of ASL-8052, a Novel β-Adrenergic Receptor Antagonist with an Ultrashort Duration of ActionJournal of Cardiovascular Pharmacology, 1983
- Verapamil disposition kinetics in chronic atrial fibrillationClinical Pharmacology & Therapeutics, 1981
- Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or FlutterAnnals of Internal Medicine, 1981
- Physiological disposition of verapamil in manCardiovascular Research, 1976